Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
臨床醫學研究所
Clinical Medicine
瀏覽統計
Email 通知
RSS Feed
關於
子單位
研究人員
14
研究成果
3561
計畫
868
單位人員研究成果
顯示/隱藏過濾條件
依作者
12
jia-horng kao
2
chun-jen liu
1
ding-shinn chen
1
hung-chih yang
1
lai m.-y.
1
lin h.-h.
1
pei-jer chen
1
song-chou hsieh
1
tung-hung su
1
wu j.-w.
.
下一頁 >
主題
7
[sdgs]sdg3
1
alanine aminotransferase; hepatitis b core antigen; hepatitis b surface antigen; hepatitis b(e) antigen; virus dna; biological marker; age; cancer growth; cancer risk; disease association; hepatitis b; hepatitis b virus genotype c; human; letter; liver cell carcinoma; liver cirrhosis; priority journal; risk factor; sex difference; hepatitis b; hepatitis b virus; liver tumor; receiver operating characteristic; biomarkers; carcinoma, hepatocellular; hepatitis b; hepatitis b virus; humans; liver neoplasms; roc curve
1
aminotransferase; hepatitis b surface antigen; hydroxychloroquine; methylprednisolone; virus dna; adult; aminotransferase blood level; case report; drug megadose; drug pulse therapy; female; hepatitis b; histopathology; human; human tissue; immunohistochemistry; interstitial lung disease; laboratory test; letter; liver biopsy; liver necrosis; priority journal; side effect; sjoegren syndrome; treatment duration; virus carrier; virus load; virus reactivation; alanine transaminase; carrier state; dna, viral; female; glucocorticoids; hepatitis b; hepatitis b e antigens; hepatitis b surface antigens; hepatitis b virus; humans; liver; middle aged; pulse therapy, drug; recurrence; virus activation
1
circular dna; covalently closed circular dna; entecavir; unclassified drug; antivirus agent; alcohol liver disease; antiviral therapy; cancer incidence; cancer patient; cancer risk; chronic hepatitis b; hepatitis b virus; human; letter; liver cell; liver cell carcinoma; liver cirrhosis; mortality rate; patient risk; priority journal; treatment duration; vaccination; virus replication; chronic hepatitis b; hepatitis b virus; liver cell carcinoma; liver tumor; treatment outcome; antiviral agents; carcinoma, hepatocellular; hepatitis b virus; hepatitis b, chronic; humans; liver cirrhosis; liver neoplasms; treatment outcome
1
hepatitis b surface antigen; hepatitis b surface antigen; membrane antigen; asian; blood level; chronic hepatitis b; clinical outcome; disease course; disease exacerbation; disease severity; gene deletion; hepatitis b virus genotype b; hepatitis b virus genotype c; human; letter; liver cell carcinoma; liver cirrhosis; nonhuman; prediction; priority journal; risk assessment; virus identification; hepatitis b virus; liver tumor; antigens, surface; carcinoma, hepatocellular; hepatitis b surface antigens; hepatitis b virus; humans; liver neoplasms
1
hepatitis b surface antigen; peginterferon; virus dna; chicken; egg; gene mutation; hepatitis b; hepatitis b virus; human; immune response; letter; priority journal; seroconversion; virus gene; virus mutant; virus strain; genes, viral; hepatitis b; hepatitis b surface antigens; hepatitis b virus; humans; interferon-alpha; male; mutation; polyethylene glycols
1
hepatitis b surface antigen; tenofovir disoproxil; hepatitis b surface antigen; hepatitis b(e) antigen; virus dna; antigen detection; disease course; gene mutation; hepatitis b; hepatitis b virus genotype a; hepatitis b virus genotype c; hepatitis b virus genotype d; host resistance; human; immunological tolerance; letter; liver cirrhosis; next generation sequencing; nonhuman; priority journal; sequence analysis; virus gene; virus replication; virus strain; chronic hepatitis b; genetics; hepatitis b; hepatitis b virus; dna, viral; hepatitis b; hepatitis b e antigens; hepatitis b surface antigens; hepatitis b virus; hepatitis b, chronic; humans
1
hepatitis b; hepatocellular carcinoma; mutations
依日期
3
2020 - 2023
5
2010 - 2019
4
2007 - 2009
全文
12
no fulltext
關閉過濾條件
再查詢
資料類型:
letter
作者:
tai-chung tseng
第 1 到 12 筆結果,共 12 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2023
Reply
TAI-CHUNG TSENG
; JIA-HORNG KAO
Gastroenterology
0
0
2
2022
Letter to the editor: New kid in the playground: HBcrAg and risk of HCC
Wu J.-W.; TAI-CHUNG TSENG
; JIA-HORNG KAO
Hepatology
0
0
3
2021
Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' reply
TAI-CHUNG TSENG
; JIA-HORNG KAO
Alimentary Pharmacology and Therapeutics
1
1
4
2019
Large and middle hepatitis B surface antigen: The lower the better?
Lin H.-H.; TAI-CHUNG TSENG
; JIA-HORNG KAO
Gut
1
1
5
2018
HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
TUNG-HUNG SU
; TAI-CHUNG TSENG
; JIA-HORNG KAO
Hepatology
11
10
6
2017
More viral mutants, less HBsAg clearance? One size may not fit all
TAI-CHUNG TSENG
; HUNG-CHIH YANG
; JIA-HORNG KAO
Gut
2
1
7
2017
HBV markers for HCC prediction: Three heads are better than two?
TAI-CHUNG TSENG
; JIA-HORNG KAO
Journal of Hepatology
6
3
8
2012
Hepatitis B virus mutants associated with hepatitis b surface antigen loss: Chicken or egg?
TAI-CHUNG TSENG
; JIA-HORNG KAO
Hepatology
0
0
9
2009
HBsAg Seroclearance: The More and Earlier, the Better
TAI-CHUNG TSENG
; JIA-HORNG KAO
Gastroenterology
4
4
10
2009
Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy
TAI-CHUNG TSENG
; CHUN-JEN LIU
; SONG-CHOU HSIEH
; PEI-JER CHEN
; Lai M.-Y.; DING-SHINN CHEN
; JIA-HORNG KAO
Digestive and Liver Disease
3
3
11
2008
HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles
TAI-CHUNG TSENG
; JIA-HORNG KAO
Gastroenterology
17
16
12
2007
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
TAI-CHUNG TSENG
; CHUN-JEN LIU
; JIA-HORNG KAO
American Journal of Gastroenterology
1
1